DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6bjwp8/narcolepsy) has announced the addition of the "Narcolepsy Pipeline Highlights - 2014 Update" report to their offering.
The latest report Narcolepsy Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Narcolepsy market. It covers emerging therapies for Narcolepsy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Narcolepsy pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Narcolepsy pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Narcolepsy pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Narcolepsy pipeline products will be launched in the US and Ex-US till 2017.
- Narcolepsy phase 3 clinical trial pipeline molecules
- Narcolepsy phase 2 clinical trial pipeline molecules
- Narcolepsy phase 1 clinical trial pipeline molecules
- Narcolepsy preclinical research pipeline molecules
- Narcolepsy discovery stage pipeline molecules
- Narcolepsy pipeline molecules short-term launch highlights
For more information visit http://www.researchandmarkets.com/research/6bjwp8/narcolepsy